11 Feb CASO CLINICO: BTKi 2° GENERAZIONE: ACALABRUTINIB vs ZANUBRUTINIB – SONDAGGIO CHIUSO Posted at 15:48h in Aggiornamenti, News by admincllmonitor 0 Comments 3 LikesTags: adult leukemia, clinical practice, CLL, cllmonitor, leukemia treatment
No Comments